Tilray Inc (TLRY) - Cash Flow Conversion Efficiency

Latest as of February 2026: -0.014x

Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.014x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-21.94 Million ≈ $-15.87 Million USD) by net assets (CA$1.53 Billion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Tilray Inc to measure how much of total assets are equity-financed.

Tilray Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Tilray Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Yingfeng Technology Co Ltd SHG:605055	N/A
Midi Utama Indonesia Tbk JK:MIDI	0.163x
Guangdong Hybribio Biotech Co Ltd SHE:300639	0.018x
Atom Hoteles Socimi MC:YATO	0.046x
Ambassador Hotel Ltd TW:2704	0.009x
Kenda Rubber Industrial Co Ltd TW:2106	-0.003x
Skjern Bank A/S CO:SKJE	0.007x
SGL Carbon SE XETRA:SGL	0.021x

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Tilray Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-05-31	CA$1.49 Billion ≈ $1.08 Billion	CA$-94.60 Million ≈ $-68.43 Million	-0.064x	-607.55%
2024-05-31	CA$3.44 Billion ≈ $2.49 Billion	CA$-30.91 Million ≈ $-22.36 Million	-0.009x	-478.05%
2023-05-31	CA$3.33 Billion ≈ $2.41 Billion	CA$7.91 Million ≈ $5.72 Million	0.002x	+105.95%
2022-05-31	CA$4.44 Billion ≈ $3.21 Billion	CA$-177.26 Million ≈ $-128.23 Million	-0.040x	-298.55%
2021-05-31	CA$4.47 Billion ≈ $3.23 Billion	CA$-44.72 Million ≈ $-32.35 Million	-0.010x	+86.24%
2020-05-31	CA$1.33 Billion ≈ $958.73 Million	CA$-96.43 Million ≈ $-69.76 Million	-0.073x	-126.78%
2019-05-31	CA$1.28 Billion ≈ $926.63 Million	CA$-41.10 Million ≈ $-29.73 Million	-0.032x	-566.53%
2018-05-31	CA$910.14 Million ≈ $658.38 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.005x	-124.75%
2017-05-31	CA$203.29 Million ≈ $147.06 Million	CA$3.95 Million ≈ $2.86 Million	0.019x	+168.90%
2016-05-31	CA$26.85 Million ≈ $19.42 Million	CA$-757.62K ≈ $-548.05K	-0.028x	+93.08%
2015-05-31	CA$10.74 Million ≈ $7.77 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.408x	-169.35%
2014-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	0.00%
2013-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	-17.18%
2012-05-31	CA$333.15K ≈ $241.00K	CA$-43.05K ≈ $-31.14K	-0.129x	--

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic

Market Cap

$548.54 Million

CA$758.29 Million CAD

Market Cap Rank

#11626 Global

#343 in Canada

Share Price

CA$6.34

Change (1 day)

+7.64%

52-Week Range

CA$0.85 - CA$19.12

All Time High

CA$26.00